lunes, 5 de agosto de 2024

FDA grants accelerated approval to afamitresgene autoleucel for unresectable or metastatic synovial sarcoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-afamitresgene-autoleucel-unresectable-or-metastatic-synovial-sarcoma

No hay comentarios: